Beta-carboline derivatives and its pharmaceuticals use against depression and anxiety

Details for Australian Patent Application No. 2002316828 (hide)

Owner Novartis AG

Inventors Hurth, Konstanze; Hoyer, Daniel; Troxler, Thomas J.

Agent Davies Collison Cave

Pub. Number AU-B-2002316828

PCT Number PCT/EP02/03624

PCT Pub. Number WO2002/081471

Priority 0108337.7 03.04.01 GB

Filing date 2 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 11 May 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 0108337.7 03.04.01 GB

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002316828

11 May 2006 Application Accepted

  Published as AU-B-2002316828

7 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316829-METHOD AND APPARATUS FOR GENERATING HIGH OUTPUT POWER GAS DISCHARGE BASED SOURCE OF EXTREME ULTRAVIOLET RADIATION AND/OR SOFT XRAYS

2002316827-NOVEL NP-PROPARGYLOXYPHENETHYL-THIOACETIC ACID AMIDES